← Evidence map

ArticleBritish journal of cancer2010

Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours.

T Gelardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 20051960